Who We Are...


Chittaranjan National Cancer Institute began its research efforts in 1957. At that time   research activities at this institute had emphasized on the understanding of the biology of cancer particularly of the predominant types viz. oral cavity and uterine cervix. Today, Research at CNCI has reorganized in its infrastructure both for basic and clinical research to include need-based contemporary as well as futuristic research areas.

The current approach is based on a programmed-oriented research in areas of identification of risk factors predominantly responsible for the development of cancer includes oral, breast, lung, ovary, colon etc..
Scientists are devoting themselves to understand the molecular mechanism of development of these cancer types and target at different stages of the disease. The collaborative efforts between scientist & clinicians are generating the new era of preclinical model development as well as new clinical trial design which ultimately helping the cancer patients.

Different arenas of investigations are going on to fight against cancer. A blend of basic as well as translational research is going on. Major areas the CNCI scientists are working include Oncogene regulation, gene therapy, receptor biology, signal transduction, cancer immunology, tumor micro-environment, cancer chemoprevention, cancer chemotherapy and anticancer drug development.
The central research instrumentation facility (CRIF) has been created in 1996 to provide centralized and modern technical facilities for oncology research.

Scientists are also contributing at CNCI for the development of future cancer scientist by mentoring them for doctoral degree as well as post-doctoral training in cancer biology.

The library has added its own literature search programmes through online journal subscription, equipped with separate e-library. Scientist, researchers and scholars participating in the research programmes published and presented their work in leading international journals and at international meetings.